Thursday, 8 December 2011

New MS pill refused again by NICE

Source MS Society:
The new pill for people with relapsing-remitting MS, called Gilenya (formerly known as fingolimod), has been refused by NICE for a second time on the grounds of poor cost effectiveness.  For more click here.